Papers
1
Total Citations
12
H-Index
1
About
Felix Mehrhof is a leading figure in the emerging field of cardiac radioablation, a non-invasive treatment for ventricular tachycardia. His work sits at the critical intersection of radiation oncology and cardiology, where he has made foundational contributions to treatment planning and standardization. Mehrhof’s most cited paper, "Treatment Planning for Cardiac Radioablation: Multicenter Multiplatform Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial" (2022, 12 citations), exemplifies his impact. This study established a rigorous, multi-institutional benchmark for treatment planning, directly enabling the landmark RAVENTA trial—a pivotal step toward clinical adoption. By harmonizing techniques across platforms and centers, Mehrhof has helped transform a promising concept into a reproducible, safe therapy. His work not only advances technical precision but also fosters the collaborative frameworks essential for translating cutting-edge physics into life-saving patient care. For students and researchers, Mehrhof’s career demonstrates how methodical, cross-disciplinary validation can bridge the gap between experimental radiotherapy and routine cardiac treatment.
Research Focus
Key Achievements
Top Papers
- 1